Katie Snead

Development of Novel Antibody–Camptothecin Conjugates

Kim K. Emmerton, P. Senter, Lauren Farr, 2020, Molecular Cancer Therapeutics.

A Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene Deletion Strains Uncovers Conserved Mechanisms of Aging.

Christopher J. Murakami, Rachel B. Brem, Mark A. McCormick, 2015, Cell metabolism.

854 SGN-B7H4V, a novel, investigational vedotin antibody-drug conjugate directed to the T cell checkpoint ligand B7-H4, shows promising activity in preclinical models

P. Treuting, R. Boyce, Jason P. Schrum, 2021, Journal for ImmunoTherapy of Cancer.

Abstract 1140: Enfortumab vedotin, a Nectin-4 directed ADC, demonstrates compelling tolerability and anti-tumor activity with intravesical instillation in preclinical models of non-muscle invasive bladder cancer

Lauren Farr, E. Trueblood, S. Sandall, 2022, Cancer Research.

1187 Enfortumab vedotin induces immunogenic cell death, elicits antitumor immune memory, and shows enhanced preclinical activity in combination with immune checkpoint inhibitors

A. Nesterova, T. Lewis, Taisuke Nakazawa, 2022, Regular and Young Investigator Award Abstracts.

Abstract 5581: Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers

A. Nesterova, T. Lewis, Bernard A. Liu, 2020 .